{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to UT MD Anderson
The University of Texas MD Anderson Cancer Center
  • Sign In
  • Home
  • Live
  • On-Demand
  • RSS/Grand Rounds
  • Non-Accredited
  • About
  • Contact Us
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

UT MD Anderson workforce members:  Select " UT MD ANDERSON LOGIN" and enter your UT MD Anderson email address and password.

Guests (all other than UT MD Anderson workforce members): Select "GUEST LOGIN" and enter your email address and password.

UT MD ANDERSON LOGIN
GUEST LOGIN
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • AA
  • AAS
  • ADN
  • BA
  • BS
  • BSN
  • DDS
  • DMD
  • DMin
  • DNP
  • DO
  • DrPH
  • DVM
  • DVM,PhD
  • EdD
  • JD
  • MA
  • MBA
  • MBBS
  • MBBS,MD
  • MD
  • MD, MBA
  • MD, MPH
  • MD, PhD
  • MDiv
  • MEd
  • MHA
  • MPA
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • Other
  • PharmD
  • PharmD, PhD
  • PhD
  • PsyD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

UT MD Anderson Cancer Center Hematopathology Update Series 2026 Course: Integration of Flow Cytometry in Diagnostic Hematopathology


LIVE

  • Overview
  • Faculty
  • Hotel
  • Register
Add to Calendar UT MD Anderson Cancer Center Hematopathology Update Series 2026 Course: Integration of Flow Cytometry in Diagnostic Hematopathology 9/19/2026 8:00:00 AM 9/20/2026 5:00:00 PM America/Chicago For More Details: https://mdanderson.cloud-cme.com/Hematopathology2026 Description: This course offers a practical update in contemporary hematopathology, emphasizing the integration of flow cytometry into diagnostic workflows. Through focused lectures and interactive case-based discussions, participants will learn how flow cytometry informs diagnosis and differential diagnosis, address common and challenging diagnostic scenarios, review emerging applications, and identify important diagnost... MD Anderson - Zayed Z2.4040, Rooms 1-6, 6565 MD Anderson Blvd false MM/DD/YYYY


Date & Location
Saturday, September 19, 2026, 8:00 AM - Sunday, September 20, 2026, 5:00 PM, MD Anderson - Zayed Z2.4040, Rooms 1-6, 6565 MD Anderson Blvd, Houston, TX

Target Audience
Specialties - Hematopathology
Professions - Other, Physician (MD or DO), Student or Trainee

Credits
AMA PRA Category 1 Credits™ (10.75 hours), ABPath MOC Part II (10.75 hours), Non-Physician Attendance (10.75 hours)

Overview
This course offers a practical update in contemporary hematopathology, emphasizing the integration of flow cytometry into diagnostic workflows. Through focused lectures and interactive case-based discussions, participants will learn how flow cytometry informs diagnosis and differential diagnosis, address common and challenging diagnostic scenarios, review emerging applications, and identify important diagnostic pitfalls.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Compare the key immunophenotypic features of myeloid and lymphoid neoplasms.
  2. Apply flow cytometry in the differential diagnosis of entities with overlapping features.
  3. Recognize technical artifacts and common diagnostic pitfalls.

Registration

Registration closes on August 31, 2026.

* Breakfast on Saturday and Sunday, as well as lunch and dinner on Saturday, are included.

You are invited to submit an interesting and challenging lymphoma and leukemia cases with flow cytometry contributing to the diagnosis. The deadline for case submission is July 15, 2026, and the notification of submission status will be August 15, 2026. 

Please click here to submit a case.


Accreditation

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation:

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 10.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Pathology MOC Credit:

This activity has been registered to offer credit in the American Board of Pathology’s Continuing Certification program. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.75 Lifelong Learning credits. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABPath MOC credit.





Additional Information

View the accessibility policy for The University of Texas MD Anderson Cancer Center.

 


Select Nearby Hotels

Hotel Name

Phone Number

Address

Distance from Conference Location (distance/walking time)

Website

The Westin Houston Medical Center/Museum District

713-730-2404

1709 Dryden Rd., Houston Tx 77030

0.5 miles |   12 minutes

https://www.marriott.com/en-us/hotels/houwa-the-westin-houston-medical-center-museum-district/overview/

Houston Marriott Medical Center/Museum District

713-796-0080

6580 Fannin St., Houston 77030

0.5 miles |   12 minutes

http://www.marriott.com/houmc  

DoubleTree by Hilton Houston Medical Center Hotel & Suites

713-528-7744

6800 Main St., Houston, TX 77030

0.8 miles |   19 minutes

https://www.hilton.com/en/hotels/houmhdt-doubletree-houston-medical-center-hotel-and-suites/     

Select Nearby Parking

Parking Location

Address                                   

Distance from Conference Location (distance/walking time)

Website

Texas Medical Center Garage 10

6700 MD Anderson Blvd., Houston, TX 77030

0.2 miles |   4 minutes

https://www.tmc.edu/parking/visitor-parking/   

Texas Medical Center Garage 6

1329 Moursund St. in Houston, TX 77030

0.5 miles |  11 minutes

https://www.tmc.edu/parking/visitor-parking/

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the educational content of a certified continuing education (CE) activity, including faculty, planners, reviewers, are required to disclose all financial relationships with ineligible companies within the prior 24 months. There is no minimum financial threshold. An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used on or by patients. All relevant financial relationships have been mitigated prior to the start of the activity.


Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Wei Wang, MD, PhD
Associate Professor, Hematopathology Adm
The University of Texas MD Anderson Cancer Center
Activity Director, Faculty
Consulting Fee-Johnson & Johnson (any division)
Bruno P. Granwehr, MD
Professor, Infectious Diseases
The University of Texas MD Anderson Cancer Center
CE Reviewer
Nothing to disclose
Sa Wang, MD, Hematopathology
Professor, Hematopathology Adm
The University of Texas MD Anderson Cancer Center
Content Reviewer, Faculty, Planning Committee Member
Nothing to disclose
Weina Chen, MD, PhD
Professor
UT Southwestern Medical Center
Faculty
Mahsa Khanlari, MD
Dr.
St. Jude Children's Research Hospital
Faculty
Nothing to disclose
Shaoying Li, MD
Professor
UT MD Anderson Cancer Center
Faculty
Nothing to disclose
Chi Young Ok, MD
Assistant Professor, Hematopathology Adm
The University of Texas MD Anderson Cancer Center
Faculty
Lianqun Qiu, MD
Assistant Professor
The University of Texas MD Anderson Cancer Center
Faculty
Nothing to disclose
Beenu Thakral, MD
Associate Professor
UT MD Anderson Cancer Center
Faculty
Nothing to disclose
Hong Fang, MD
Assistant Professor
MD Anderson Cancer Center
Faculty, Planning Committee Member
Nothing to disclose
Jinfeng S Gross, PhD
Lab Supervisor
MD Anderson Cancer Center
Faculty, Planning Committee Member
Nothing to disclose
Vasiliki Leventaki, MD
Associate Professor
The University of Texas MD Anderson Cancer Center
Faculty, Planning Committee Member
Nothing to disclose
Jie Xu, MD
Associate Professor, Hematopathology Adm
The University of Texas MD Anderson Cancer Center
Faculty, Planning Committee Member
Nothing to disclose

Saturday, September 19, 2026
 
Day 1

Registration/badge/breakfast
7:30AM - 8:15AM

Welcome and course overview
8:15AM - 8:30AM
Sa Wang, MD, Hematopathology

Overview: Flow cytometry in detecting abnormal cells: Diagnostic strategies and common pitfalls
8:30AM - 8:55AM
Wei Wang, MD, PhD

How preanalytical and technical factors affect flow cytometry data quality
8:55AM - 9:20AM
Jinfeng S Gross, PhD

Plasma cell neoplasms: Initial diagnosis and MRD detection
9:20AM - 9:45AM
Chi Young Ok, MD

Case Based Discussion: Plasma cell neoplasm or lymphoma in disguise ?
9:45AM - 9:55AM
Chi Young Ok, MD

Coffee Break
9:55AM - 10:30AM
 
10:30–12:25 am

CD5+B cell lymphoma/leukemia including CLL-MRD detection
10:30AM - 10:55AM
Lianqun Qiu, MD

Case Based Discussion: CD5 positive B-cell neoplasm, can we classify it ?
10:55AM - 11:05AM
Lianqun Qiu, MD

CD5-CD10 B-Cell Lymphoma/leukemia including splenic B-cell neoplasms and hairy cell leukemia and variants
11:05AM - 11:30AM
Beenu Thakral, MD

Case Based Discussion: Hairy cell leukemia, classic or not ?
11:30AM - 11:40AM
Beenu Thakral, MD

Follicular lymphoma, diffuse large B-cell lymphoma and high-grade B-cell lymphoma
11:40AM - 12:05PM
Shaoying Li, MD

Case Based Discussion: Blastoid B cell neoplasm with a leukemic presentation, immature or mature ?
12:05PM - 12:15PM
Shaoying Li, MD

Case Based Discussion: Diagnostic challenges in B-cell lymphomas
12:15PM - 12:25PM
Shaoying Li, MD

 
Lunch

Lunch
12:25PM - 1:30PM

 
1:30–3:00pm

Blood and bone marrow-based T/NK cell leukemia/lymphoma
1:30PM - 1:55PM
Hong Fang, MD

Case Based Discussion: Large granular lymphocytic proliferations
1:55PM - 2:05PM
Hong Fang, MD

Case Based Discussion: A perplexing mature T-cell leukemia
2:05PM - 2:15PM
Hong Fang, MD

Nodal and tissue-based T/NK cell Lymphoma
2:15PM - 2:40PM
Jie Xu, MD

Case Based Discussion: A T-cell neoplasm with deceptive features
2:40PM - 2:50PM
Jie Xu, MD

Case Based Discussion: A T-cell lymphoma with a follicular helper phenotype
2:50PM - 3:00PM
Jie Xu, MD

 
Coffee Break

Coffee Break
3:00PM - 3:30PM

 
3:30–5:30 pm

Acute Myeloid Leukemia
3:30PM - 4:00PM
Wei Wang, MD, PhD

Case Based Discussion: An acute leukemia requiring urgent recognition
4:00PM - 4:10PM
Wei Wang, MD, PhD

Case Based Discussion: An erythoid predominant marrow, when is it acute leukemia ?
4:10PM - 4:20PM
Wei Wang, MD, PhD

Acute myeloid leukemia MRD and Chronic myeloid neoplasms
4:20PM - 5:00PM
Sa Wang, MD, Hematopathology

Case Based Discussion: When abnormal cells no longer resemble their original immunophenotype #1
5:00PM - 5:10PM
Sa Wang, MD, Hematopathology

Case Based Discussion: When abnormal cells no longer resemble their original immunophenotype #2
5:10PM - 5:20PM
Sa Wang, MD, Hematopathology

Case Presentation:Abnormal Phenotype in Myelomonocytic cells, MDS
5:20PM - 5:30PM
Sa Wang, MD, Hematopathology

Sunday, September 20, 2026
 
Day 2

Breakfast
7:30AM - 8:00AM
 
8:00–10:05 am

Initial diagnosis of acute lymphoblastic leukemia (B and T)
8:00AM - 8:25AM
Vasiliki Leventaki, MD

Case based discussion: A T-cell neoplasm with a mature phenotype presenting as acute leukemia
8:25AM - 8:35AM
Vasiliki Leventaki, MD

Case based discussion: An acute leukemia with genetic implication
8:35AM - 8:45AM
Vasiliki Leventaki, MD

Acute lymphoblastic leukemia MRD Detection (Include B-ALL and T-ALL)
8:45AM - 9:10AM
Mahsa Khanlari, MD

Case based discussion: When MRD no longer resembles the original leukemia
9:10AM - 9:20AM
Mahsa Khanlari, MD

Mixed phenotype acute leukemia
9:20AM - 9:45AM
Weina Chen, MD, PhD

Case based discussion: An acute leukemia with lineage ambiguity
9:45AM - 9:55AM
Weina Chen, MD, PhD

Case based discussion: An acute leukemia with a minor unexpected population
9:55AM - 10:05AM
Weina Chen, MD, PhD

 
Coffee Break

Coffee Break
10:05AM - 10:30AM

 
10:30–12:00 pm

Systemic mastocytosis
10:30AM - 10:50AM
Jie Xu, MD

Case based discussion: Systemic mastocytosis or something more?
10:50AM - 11:00AM
Jie Xu, MD

BPDCN including MRD assessment
11:00AM - 11:20AM
Wei Wang, MD, PhD

Case based discussion: A plasmacytoid dendritic cell proliferation in the setting of myeloid neoplasm
11:20AM - 11:30AM
Wei Wang, MD, PhD

CAR T cell quanification by flow cytometry
11:30AM - 11:50AM
Sa Wang, MD, Hematopathology

Case based discussion: Enteritis in the setting of immune effector cell therapy
11:50AM - 12:00PM
Sa Wang, MD, Hematopathology

 
Closing

Course Summary, Key Takeaways and closing remarks
12:00PM - 12:15PM

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030
 Privacy policies   

©2026 The University of Texas MD Anderson Cancer Center
Contact Us: [email protected]

See us on Facebook See us on Twitter See us on Linked In See us on Instagram